Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet HUMIRA 40mg solution for injection in pre-filled syringe with needle guard
- Product code:
- W59952001
- Quantity:
- 1
- Indicated for:
- inflammatory bowel disease
- Route of administration:
- injectable
- Substance:
- adalimumab (monoclonal antibody)
- ATC
- L04AB04 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors
Precautions:
Avoid live vaccines
Avoid live vaccines during treatment if contraindicated.
Immunosuppression / infection risk
This medicine may increase the risk of infections.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Adalimumab is a biologic medication used to treat autoimmune inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. It works by inhibiting tumor necrosis factor-alpha (TNF-α), a protein involved in inflammation.
It is administered as subcutaneous injections, usually once every two weeks, depending on the medical indication. Adalimumab helps reduce inflammation, alleviate symptoms, and prevent joint damage.
Side effects may include injection site reactions, respiratory infections, headaches, or nausea. In rare cases, it may increase the risk of severe infections or certain types of cancer.
Patients should be regularly monitored by their doctor and report any signs of infection or other health issues. It is contraindicated in cases of active severe infections.
It is administered as subcutaneous injections, usually once every two weeks, depending on the medical indication. Adalimumab helps reduce inflammation, alleviate symptoms, and prevent joint damage.
Side effects may include injection site reactions, respiratory infections, headaches, or nausea. In rare cases, it may increase the risk of severe infections or certain types of cancer.
Patients should be regularly monitored by their doctor and report any signs of infection or other health issues. It is contraindicated in cases of active severe infections.
General data about HUMIRA 40mg
- Substance:
- adalimumab
- Date of latest medicines list:
- 02-10-2013
- Product code:
- W59952001
- Concentration:
- 40mg
- Pharmaceutical form:
- solution for injection in pre-filled syringe with needle guard
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for adalimumab
Concentrations available for adalimumab
- 20mg
- 20mg/0.2ml
- 20mg/0.4ml
- 40mg
- 40mg/0.4ml
- 40mg/0.8ml
- 80mg
- 80mg/0.8ml